Enterococcus is a genus of Gram-positive bacteria that is composed of more than seventy different species found in diverse environments, both free-living and in relationships with various animals (Lebreton et al., 2017). Enterococcus faecium strains have been isolated from humans and reported to have both beneficial and pathogenic properties (Van Tyne and Gilmore, 2014). Notably, antibiotic-resistant strains of E. faecium, particularly vancomycin-resistant E. faecium (VREfm), have emerged as major causes of healthcare-associated infections (Van Tyne and Gilmore, 2014; Fiore et al., 2019; García-Solache and Rice, 2019), and have been correlated with graft-versus-host disease (GVHD) and increased mortality in allogeneic hematopoietic cell transplantation patients (Stein-Thoeringer et al., 2019). E. faecium has also been recovered from ulcerative colitis and Crohn’s disease patients and has been shown to exacerbate intestinal inflammation and colitis in mouse models of inflammatory bowel disease (IBD) Barnett et al., 2010; Seishima et al., 2019. However, commensal strains of E. faecium have also been reported to enhance intestinal immunity in animal models and have been developed as probiotics (Hanchi et al., 2018). Furthermore, microbiota analysis has shown that E. faecium was enriched in immune checkpoint inhibitor (ICI) (Gopalakrishnan et al., 2018; Routy et al., 2018; Matson et al., 2018) and chimeric antigen receptor (CAR) T-cell therapy-responsive patients (Smith et al., 2022). These studies highlight the potential pathogenic and beneficial features of E. faecium.

Our laboratory previously investigated the beneficial effects of E. faecium on host physiology (Griffin and Hang, 2022). We demonstrated that secreted antigen A (SagA), a highly conserved NlpC/P60 peptidoglycan hydrolase in E. faecium, was sufficient to confer protection against enteric infections in both Caenorhabditis elegans and mice (Rangan et al., 2016). In mice, E. faecium and an E. faecalis strain engineered to express SagA both up-regulated expression of mucins and antimicrobial peptides, resulting in improved intestinal barrier function as well as tolerance to Salmonella enterica serovar Typhimurium and Clostridioides difficile pathogenesis (Pedicord et al., 2016; Kim et al., 2019). In contrast, wild-type E. faecalis, which does not express SagA, did not exhibit these effects. We then determined the X-ray crystal structure of the SagA NlpC/P60 hydrolase domain, and demonstrated that this hydrolase preferentially cleaves crosslinked peptidoglycan fragments into smaller muropeptides (such as GlcNAc-MDP), which more effectively activate the peptidoglycan pattern recognition receptor NOD2 (nucleotide-binding oligomerization domain-containing protein 2) in mammalian cells (Kim et al., 2019). Importantly, NOD2 was shown to be required for E. faecium stimulation of intestinal immunity and tolerance to infection in vivo (Pedicord et al., 2016; Kim et al., 2019). Moreover, E. faecium and SagA were sufficient to protect mice against dextran sodium sulfate-induced colitis that required the expression of NOD2 in myeloid cells (Jang et al., 2023).

The discovery of E. faecium among the microbiota of cancer immunotherapy-responsive patients then motivated our analysis of Enterococcus species and SagA in mouse tumor models. Indeed, diverse strains of E. faecium that express SagA, but none of the non-SagA-expressing E. faecalis strains evaluated, were sufficient to promote ICI (anti-PD-L1, anti-PD-1, anti-CTLA-4) anti-tumor activity against different cancer types in mouse models (Griffin et al., 2021). Furthermore, other Enterococcus species including E. durans, E. hirae, and E. mundtii, which each have SagA orthologs with greater than 80% protein similarity to that of E. faecium, were sufficient to enhance anti-PD-L1 antitumor activity (Griffin et al., 2021). The SagA orthologs from these other Enterococcus species were expressed and secreted at similar levels to E. faecium SagA and showed similar peptidoglycan hydrolase activity in vitro (Griffin et al., 2021). Importantly, heterologous expression of SagA in inactive bacterial species (E. faecalis and Lactococcus lactis) was sufficient to promote anti-PD-L1 antitumor activity and required NOD2 in vivo (Griffin et al., 2021). Collectively, these studies demonstrated that Enterococcus peptidoglycan remodeling by SagA is sufficient to enhance intestinal immunity against infection and promote cancer immunotherapy. However, the endogenous functions of SagA in E. faecium microbiology and modulation of host immunity were not investigated previously, as sagA was believed to be an essential gene in E. faecium (strain TX1330), as reported by Murray and coworkers (Teng et al., 2003). Nevertheless, our collaborative studies with the Duerkop laboratory have indicated that phage-resistant strains of E. faecium (strain Com12) containing catalytically inactivating point mutations in sagA were still viable (Canfield et al., 2023), suggesting that SagA may not be essential and could be functionally evaluated in E. faecium.

Here, we report the generation of a ΔsagA strain of E. faecium (Com15). This strain, generated using RecT-mediated recombineering methods developed by our laboratory (Chen et al., 2021), exhibited significantly impaired growth (Figure 1a) and sedimentation in liquid culture (Figure 1—figure supplement 1b). We then performed whole-genome sequencing to assess the fidelity of the ΔsagA strain’s genome to that of wild-type. While ΔsagA contained 14 mutations, most were outside of open-reading frames (ORFs) or were in genes that are unrelated to peptidoglycan metabolism (Supplementary file 1). One notable mutation, however, was in the predicted glycosidase EFWG_00994. This mutation, L200F, alters a leucine residue that is conserved among GH73 family members and the other putative Com15 glucosaminidases (Supplementary file 1). To confirm that the ΔsagA growth defect was truly SagA-dependent and was not an outcome of suppressor mutations, we generated a complementation strain (ΔsagA/ psagA) that contained a plasmid expressing sagA under control of its native promoter. Western blot analysis with ɑ-SagA polyclonal serum confirmed the deletion and complementation of SagA (Figure 1b). Differential interference contrast (DIC) microscopy revealed that ΔsagA cells form irregular clusters, as opposed to the typical wild-type morphology of diplococci or short chains (Figure 1c). This cell morphology suggested that dividing ΔsagA cells may be unable to separate from one another during binary fission. Indeed, transmission electron microscopy (TEM) of chemically fixed samples confirmed that ΔsagA cells have defects in cell separation (Figure 1d). Division septa could form and mature in these cells; however, daughter cells failed to separate, resulting in clusters of unseparated cells. Cells on the periphery of these clusters were highly strained, and in some cases appeared to lyse and leave behind strands of undegraded peptidoglycan (Figure 1d). Importantly, the complementation largely restored the log-phase growth rate and stationary-phase OD of the ΔsagA strain to those of wild-type (Figure 1a). It also reversed the liquid-culture sedimentation phenotype (Figure 1—figure supplement 1b) and reduced the cell clustering (Figure 1c) and defective septal separation (Figure 1d).

Figure 1 with 2 supplements see all

Download asset Open asset

Figure 1—source data 1

Excel file containing numeric data used to generate Figure 1a.

https://cdn.elifesciences.org/articles/95297/elife-95297-fig1-data1-v1.xlsx

Download elife-95297-fig1-data1-v1.xlsx

Figure 1—source data 2

Uncropped western blots and gels (total protein) used to generate Figure 1b.

https://cdn.elifesciences.org/articles/95297/elife-95297-fig1-data2-v1.zip

Download elife-95297-fig1-data2-v1.zip

Figure 1—source data 3

Uncropped images used to generate Figure 1c.

https://cdn.elifesciences.org/articles/95297/elife-95297-fig1-data3-v1.zip

Download elife-95297-fig1-data3-v1.zip

Figure 1—source data 4

Uncropped images used to generate Figure 1d.

https://cdn.elifesciences.org/articles/95297/elife-95297-fig1-data4-v1.zip

Download elife-95297-fig1-data4-v1.zip

Figure 1—source data 5

Validation of sagA deletion and image of bacterial strain growth.

Uncropped images used to generate Figure 1d.

https://cdn.elifesciences.org/articles/95297/elife-95297-fig1-data5-v1.zip

Download elife-95297-fig1-data5-v1.zip

To investigate the significance of peptidoglycan hydrolase activity in SagA, we generated a catalytically inactive point mutant (C431A) in our sagA complementation plasmid. Consistent with our previous biochemical results on recombinant SagA NlpC/P60 domain activity (Kim et al., 2019; Espinosa et al., 2020), the C431A mutant was unable to complement the sagA deletion (Figure 1a–d), despite Western blot analysis confirming that the mutant SagA was expressed and secreted properly (Figure 1b). Together, these results demonstrated that catalytically active SagA is required for proper E. faecium growth.

Based on the growth defect of ΔsagA and the previously reported antibiotic sensitization effect of catalytically inactivating point mutants in the SagA of E. faecium strain Com12 (Canfield et al., 2023), we chose to investigate the impact of the sagA deletion on the effectiveness of various cell wall-acting antibiotics. Using minimum inhibitory concentration (MIC) test strips of common antibiotics (vancomycin, linezolid, daptomycin, tigecycline, telavancin, fosfomycin, ampicillin, ceftriaxone, and imipenem), we observed increased sensitivity to the β-lactams (ampicillin, ceftriaxone, and imipenem), moderately increased sensitivity to daptomycin, tigecycline, fosfomycin, and linezolid and no change in sensitivity to telavancin and vancomycin (Figure 1—figure supplement 2a, Supplementary file 2). MIC analysis of ampicillin in liquid culture, further demonstrated that ΔsagA has increased susceptibility to β-lactam antibiotics, which was abrogated with psagA expression (Figure 1—figure supplement 2b).

To further investigate the growth defect and increased β-lactam antibiotic sensitivity of ΔsagA, we performed cryo-electron tomography (cryo-ET) on frozen-hydrated samples to quantify factors such as peptidoglycan thickness, septum thickness, and placement of divisome components at a higher resolution (Figure 2—figure supplement 1a and b). There was no statistically significant change in peptidoglycan thickness and septum thickness in ΔsagA and ΔsagA/ psagA cells compared to wild-type cells (Figure 2—figure supplement 1c and d). Similar to previous studies of Bacillus subtilis (Khanna et al., 2021), the divisome machinery was directly observable as concentric rings in cross-sectional images generated by cryo-ET in E. faecium (Figure 2—figure supplement 2a–d). We quantified the distances from these rings in order to assess potential differences in divisome placement (Figure 2—figure supplement 2e). The distance between the septal membrane and the distal ring of the divisome showed a slight increase, but we did not observe any statistical difference between the distance from the septal membrane to the proximal ring and the ratio between the proximal and distal rings in wild-type, ΔsagA, and complementation (Figure 2—figure supplement 1e, Figure 2—figure supplement 2f and g). However, we observed that the placement and projection angle of growing septa were significantly altered in ΔsagA but were mostly restored by complementation (Figure 2a–f). Both room temperature TEM and cryo-ET revealed that sagA complementation largely restored the wild-type cell morphology of ΔsagA to that of wild-type (Figure 2, Figure 2—figure supplements 1 and 2). The complemented cells separate from one another and mostly take the form of diplococci. These results suggest that the ultrastructure of the peptidoglycan cell wall is unchanged as a result of sagA deletion, but peptidoglycan cleavage, divisome angle, and septal resolution are impaired.

Figure 2 with 2 supplements see all

Download asset Open asset

Figure 2—source data 1

Excel file containing numeric data to generate Figure 2e–f.

https://cdn.elifesciences.org/articles/95297/elife-95297-fig2-data1-v1.xlsx

Download elife-95297-fig2-data1-v1.xlsx

We then investigated ΔsagA peptidoglycan composition and activation of NOD2 immune signaling. To evaluate peptidoglycan composition, E. faecium sacculi were isolated, subjected to mutanolysin digestion, analyzed by liquid chromatography mass spectrometry (Figure 3—figure supplement 1) and quantified (Figure 3a and b), as previously described (Kim et al., 2019). The ΔsagA strain showed decreased levels of small muropeptides (peaks 2, 3, and 7 with green asterisk) compared to E. faecium Com15, which was restored in ΔsagA/ psagA (Figure 3a). Moreover, we observed increased amounts of crosslinked peptidoglycan fragments (peaks 13 and 14 with purple asterisk) (Figure 3a). Notably, GlcNAc-MDP, which we previously demonstrated more effectively activates NOD2 (Kim et al., 2019), was significantly decreased in ΔsagA (Figure 3b). We next evaluated live bacterial cultures with mammalian cells to determine their ability to activate the peptidoglycan pattern recognition receptor NOD2. Indeed, our analysis of these bacterial strains using HEK-Blue NF-κB reporter cells demonstrated that ΔsagA exhibits significantly decreased NOD2 activation compared to E. faecium WT. This activation was restored in ΔsagA/ psagA (Figure 3c). For these assays, we used comparable numbers of bacteria to account for defects in ΔsagA growth, which was confirmed by colony-forming unit analysis of bacteria per well (Figure 3d). These results were consistent with our in vitro analysis of recombinant SagA with purified peptidoglycan fragments, which showed that the generation of small muropeptides (GlcNAc-MDP) more potently activated NOD2 compared to crosslinked muropeptides (Kim et al., 2019). Our results also demonstrated that while many enzymes are required for the biosynthesis and remodeling of peptidoglycan in E. faecium, SagA is essential for generating NOD2-activating muropeptides ex vivo.

Figure 3 with 1 supplement see all

Download asset Open asset

Figure 3—source data 1

Excel file containing numeric data used to generate Figure 3a and c–e.

https://cdn.elifesciences.org/articles/95297/elife-95297-fig3-data1-v1.xlsx

Download elife-95297-fig3-data1-v1.xlsx

We next investigated if SagA is crucial for E. faecium colonization and immune modulation in vivo using well-established mouse models of ICI cancer immunotherapy (Figure 4a). We had previously demonstrated that heterologous expression of SagA was sufficient to promote E. faecalis and L. lactis ICI antitumor activity and required Nod2 expression in mice (Griffin et al., 2021). However, activity of wild-type E. faecium in Nod2^-/- mice was not determined. Indeed, oral administration of E. faecium to microbiota-depleted/antibiotic-treated C57BL/6 mice promoted anti-PD-1 antitumor activity against MC-38 tumor growth in Nod2^+/-, but failed to do so in Nod2^-/- mice (Figure 4b). To determine if SagA is required for E. faecium function in vivo, antibiotic-treated mice were colonized with E. faecium Com15 or ΔsagA. Notably, the antitumor activity of E. faecium was abolished in ΔsagA strain (Figure 4c) even though both bacterial strains colonized mice at comparable levels, as judged by fecal E. faecium levels (Figure 4d). We then performed immune profiling of tumor infiltrating lymphocytes (TILs) using flow cytometry (Figure 4—figure supplement 1). Compared to E. faecium Com15 colonized mice, ΔsagA colonized mice showed no difference in the total amount of the tumor-infiltrating CD45⁺ cells (Figure 4e) or CD4⁺ FoxP3+ regulatory T cells (Figure 4f), but resulted in fewer CD3⁺ CD8⁺ T cells (Figure 4g). Furthermore, granzymeB⁺ CD8⁺ T cells, Ki67⁺ CD8⁺ T cells, and PD-1⁺ CD8⁺ T cells levels were also lower in ΔsagA colonized mice (Figure 4h–j). We evaluated the activity ΔsagA/psagA strain in these experiments (data not shown), but the results were inconclusive likely due to instability of psagA plasmid in E. faecium in vivo. We note that by continuous oral administration in the drinking water, live E. faecium and soluble muropeptides that are released into the media during bacterial growth may both contribute to NOD2 activation in vivo. Nonetheless, these results demonstrate SagA is not essential for E. faecium colonization, but is required for promoting the ICI antitumor activity through NOD2 in vivo.

Figure 4 with 1 supplement see all

Download asset Open asset

Figure 4—source data 1

Excel file containing numeric data used to generate Figure 4b–j.

https://cdn.elifesciences.org/articles/95297/elife-95297-fig4-data1-v1.xlsx

Download elife-95297-fig4-data1-v1.xlsx

E. faecium is a prominent microbiota species and pathogen in animals and humans. While E. faecium identification and dominance in fecal microbiota have been correlated with health and disease outcomes, the underlying mechanisms have only begun to emerge. Our previous gain-of-function studies with recombinant protein and engineered bacterial strains demonstrated that SagA, a unique secreted peptidoglycan hydrolase that is highly conserved in E. faecium strains and other Enterococcus species, but not E. faecalis, is sufficient to activate NOD2 and promote host immunity in vivo (Rangan et al., 2016; Pedicord et al., 2016; Kim et al., 2019; Griffin et al., 2021). However, the endogenous functions of SagA in E. faecium were unknown. Based on the results described above, we now show that SagA peptidoglycan hydrolase activity is not required for E. faecium viability, but is essential for proper growth and specifically for septal separation following cell division (Figures 1 and 2). These results are consistent with key peptidoglycan hydrolases in other bacterial species, such as AmiA/B in Escherichia coli (Yang et al., 2011), CwlO/LytE in Bacillus subtilis (Meisner et al., 2013; Wilson et al., 2023), PcsB in Streptococcus pneumoniae (Sham et al., 2011) and RipC in Mycobacterium tuberculosis (Mavrici et al., 2014). Although the mechanisms of regulation may differ amongst peptidoglycan hydrolases and remain to be determined for SagA, the sagA promoter contains sequence motifs that may be regulated by WalRK two-component systems (Brogan and Rudner, 2023) and the SagA protein contains a N-terminal coil-coil domain that may interact with E. faecium divisome components, which warrants further investigation in the future. Notably, the deletion of sagA in E. faecium Com15 also renders this strain more susceptible to cell wall-acting antibiotics (Figure 1—figure supplement 2), akin to inactive SagA variants in E. faecium Com12 (Canfield et al., 2023), suggesting SagA and its related peptidoglycan hydrolases may be potential antibacterial targets to use in combination with existing antibiotics. Interestingly, clade B strains of E. faecium including Com12 and Com15 have been suggested to be reclassified as Enterococcus lactis based on genomic and phenotypic similarity (Belloso Daza et al., 2022; Belloso Daza et al., 2021). Nonetheless, SagA orthologs have greater than 90 percent protein sequence identity within the C-terminal NlpC/P60 hydrolase domain of ICI therapy-promoting Enterococcus species (E. faecium-clade A and B, E. durans, E. hirae and E. mundtii) (Griffin et al., 2021). Notably, all the Enterococcus strains and species that express active SagA orthologs that we have analyzed promote ICI cancer immunotherapy in mouse models (Griffin et al., 2021).

Beyond intrinsic functions in E. faecium microbiology, we have also demonstrated for the first time that SagA is essential for the activation of host immunity. Notably, we showed that ΔsagA does not generate significant amounts of non-crosslinked muropeptides (i.e. GlcNAc-MDP) that are sensed by the peptidoglycan pattern recognition receptor NOD2 (Figure 3). Indeed, ΔsagA failed to activate NOD2 ex vivo (Figure 3) and promote ICI antitumor activity in mouse models compared to wild-type E. faecium (Figure 4). Collectively, our results provide important mechanistic insight on SagA in peptidoglycan remodeling for bacterial cell separation and reveal an essential feature of E. faecium (Figure 5) and other related Enterococcus species that are associated with human health, disease, and response to therapy.

Figure 5

Download asset Open asset

All data generated within this study are available in the article. Cryo-ET raw data and representative tomograms have been deposited to the Electron Microscopy Public Image Archive under accession number EMPIAR-11692 and Electron Microscopy Data Bank under accession numbers EMD-42074, EMD-42086, and EMD-42087.

1. 1. Klupt S
   2. Fam KT
   3. Zhang X
   4. Chodisetti PK
   5. Mehmood A
   6. Boyd T
   7. Grotjahn D
   8. Park D
   9. Hang HC

   (2024) Electron Microscopy Public Image Archive

   ID EMPIAR-11692. Cryo-electron tomography of Enterococcus faecium.

   https://www.ebi.ac.uk/empiar/EMPIAR-11692
2. 1. Hang HC
   2. Park D

   (2024) EMDataBank

   ID EMD-42074. Representative tomogram of Enterococcus faecium WT Com15.

   https://www.ebi.ac.uk/emdb/EMD-42074
3. 1. Hang HC
   2. Park D

   (2024) EMDataBank

   ID EMD-42086. Representative tomogram of Enterococcus faecium SagA complementation strain.

   https://www.ebi.ac.uk/emdb/EMD-42086
4. 1. Hang HC
   2. Park D

   (2024) EMDataBank

   ID EMD-42087. Representative tomogram of Enterococcus faecium SagA deletion strain.

   https://www.ebi.ac.uk/emdb/EMD-42087

1. 1. Barnett MPG
   2. McNabb WC
   3. Cookson AL
   4. Zhu S
   5. Davy M
   6. Knoch B
   7. Nones K
   8. Hodgkinson AJ
   9. Roy NC

   (2010) Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species

   BMC Immunology 11:39.

   https://doi.org/10.1186/1471-2172-11-39

   • PubMed
   • Google Scholar
2. 1. Belloso Daza MV
   2. Cortimiglia C
   3. Bassi D
   4. Cocconcelli PS

   (2021) Genome-based studies indicate that the Enterococcus faecium Clade B strains belong to Enterococcus lactis species and lack of the hospital infection associated markers

   International Journal of Systematic and Evolutionary Microbiology 71:004948.

   https://doi.org/10.1099/ijsem.0.004948

   • PubMed
   • Google Scholar
3. 1. Belloso Daza MV
   2. Almeida-Santos AC
   3. Novais C
   4. Read A
   5. Alves V
   6. Cocconcelli PS
   7. Freitas AR
   8. Peixe L

   (2022) Distinction between Enterococcus faecium and Enterococcus lactis by a gluP PCR-Based Assay for Accurate Identification and Diagnostics

   Microbiology Spectrum 10:e0326822.

   https://doi.org/10.1128/spectrum.03268-22

   • PubMed
   • Google Scholar
4. 1. Brogan AP
   2. Rudner DZ

   (2023) Regulation of peptidoglycan hydrolases: localization, abundance, and activity

   Current Opinion in Microbiology 72:102279.

   https://doi.org/10.1016/j.mib.2023.102279

   • PubMed
   • Google Scholar
5. 1. Canfield GS
   2. Chatterjee A
   3. Espinosa J
   4. Mangalea MR
   5. Sheriff EK
   6. Keidan M
   7. McBride SW
   8. McCollister BD
   9. Hang HC
   10. Duerkop BA

   (2023) Lytic bacteriophages facilitate antibiotic sensitization of Enterococcus faecium

   Antimicrobial Agents and Chemotherapy 65:e00143-21.

   https://doi.org/10.1128/AAC.00143-21

   • PubMed
   • Google Scholar
6. 1. Chen V
   2. Griffin ME
   3. Maguin P
   4. Varble A
   5. Hang HC

   (2021) RecT recombinase expression enables efficient gene editing in Enterococcus spp

   Applied and Environmental Microbiology 87:e0084421.

   https://doi.org/10.1128/AEM.00844-21

   • PubMed
   • Google Scholar
7. 1. Eisenstein F
   2. Yanagisawa H
   3. Kashihara H
   4. Kikkawa M
   5. Tsukita S
   6. Danev R

   (2023) Parallel cryo electron tomography on in situ lamellae

   Nature Methods 20:131–138.

   https://doi.org/10.1038/s41592-022-01690-1

   • PubMed
   • Google Scholar
8. 1. Espinosa J
   2. Lin T-Y
   3. Estrella Y
   4. Kim B
   5. Molina H
   6. Hang HC

   (2020) Enterococcus NlpC/p60 peptidoglycan hydrolase SagA localizes to sites of cell division and requires only a catalytic dyad for protease activity

   Biochemistry 59:4470–4480.

   https://doi.org/10.1021/acs.biochem.0c00755

   • PubMed
   • Google Scholar
9. 1. Fiore E
   2. Van Tyne D
   3. Gilmore MS

   (2019) Pathogenicity of Enterococci

   Microbiology Spectrum 7:2018.

   https://doi.org/10.1128/microbiolspec.GPP3-0053-2018

   • PubMed
   • Google Scholar
10. 1. García-Solache M
    2. Rice LB

    (2019) The enterococcus: a model of adaptability to its environment

    Clinical Microbiology Reviews 32:e00058-18.

    https://doi.org/10.1128/CMR.00058-18

    • PubMed
    • Google Scholar
11. 1. Goddard TD
    2. Huang CC
    3. Meng EC
    4. Pettersen EF
    5. Couch GS
    6. Morris JH
    7. Ferrin TE

    (2018) UCSF ChimeraX: Meeting modern challenges in visualization and analysis

    Protein Science 27:14–25.

    https://doi.org/10.1002/pro.3235

    • PubMed
    • Google Scholar
12. 1. Gopalakrishnan V
    2. Spencer CN
    3. Nezi L
    4. Reuben A
    5. Andrews MC
    6. Karpinets TV
    7. Prieto PA
    8. Vicente D
    9. Hoffman K
    10. Wei SC
    11. Cogdill AP
    12. Zhao L
    13. Hudgens CW
    14. Hutchinson DS
    15. Manzo T
    16. Petaccia de Macedo M
    17. Cotechini T
    18. Kumar T
    19. Chen WS
    20. Reddy SM
    21. Szczepaniak Sloane R
    22. Galloway-Pena J
    23. Jiang H
    24. Chen PL
    25. Shpall EJ
    26. Rezvani K
    27. Alousi AM
    28. Chemaly RF
    29. Shelburne S
    30. Vence LM
    31. Okhuysen PC
    32. Jensen VB
    33. Swennes AG
    34. McAllister F
    35. Marcelo Riquelme Sanchez E
    36. Zhang Y
    37. Le Chatelier E
    38. Zitvogel L
    39. Pons N
    40. Austin-Breneman JL
    41. Haydu LE
    42. Burton EM
    43. Gardner JM
    44. Sirmans E
    45. Hu J
    46. Lazar AJ
    47. Tsujikawa T
    48. Diab A
    49. Tawbi H
    50. Glitza IC
    51. Hwu WJ
    52. Patel SP
    53. Woodman SE
    54. Amaria RN
    55. Davies MA
    56. Gershenwald JE
    57. Hwu P
    58. Lee JE
    59. Zhang J
    60. Coussens LM
    61. Cooper ZA
    62. Futreal PA
    63. Daniel CR
    64. Ajami NJ
    65. Petrosino JF
    66. Tetzlaff MT
    67. Sharma P
    68. Allison JP
    69. Jenq RR
    70. Wargo JA

    (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients

    Science 359:97–103.

    https://doi.org/10.1126/science.aan4236

    • PubMed
    • Google Scholar
13. 1. Griffin ME
    2. Espinosa J
    3. Becker JL
    4. Luo J-D
    5. Carroll TS
    6. Jha JK
    7. Fanger GR
    8. Hang HC

    (2021) Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy

    Science 373:1040–1046.

    https://doi.org/10.1126/science.abc9113

    • PubMed
    • Google Scholar
14. 1. Griffin ME
    2. Hang HC

    (2022) Microbial mechanisms to improve immune checkpoint blockade responsiveness

    Neoplasia 31:100818.

    https://doi.org/10.1016/j.neo.2022.100818

    • PubMed
    • Google Scholar
15. 1. Hanchi H
    2. Mottawea W
    3. Sebei K
    4. Hammami R

    (2018) The Genus Enterococcus: Between Probiotic Potential and Safety Concerns-An Update

    Frontiers in Microbiology 9:1791.

    https://doi.org/10.3389/fmicb.2018.01791

    • PubMed
    • Google Scholar
16. 1. Jang KK
    2. Heaney T
    3. London M
    4. Ding Y
    5. Putzel G
    6. Yeung F
    7. Ercelen D
    8. Chen YH
    9. Axelrad J
    10. Gurunathan S
    11. Zhou C
    12. Podkowik M
    13. Arguelles N
    14. Srivastava A
    15. Shopsin B
    16. Torres VJ
    17. Keestra-Gounder AM
    18. Pironti A
    19. Griffin ME
    20. Hang HC
    21. Cadwell K

    (2023) Antimicrobial overproduction sustains intestinal inflammation by inhibiting Enterococcus colonization

    Cell Host & Microbe 31:1450–1468.

    https://doi.org/10.1016/j.chom.2023.08.002

    • PubMed
    • Google Scholar
17. 1. Khanna K
    2. Lopez-Garrido J
    3. Sugie J
    4. Pogliano K
    5. Villa E

    (2021) Asymmetric localization of the cell division machinery during Bacillus subtilis sporulation

    eLife 10:e62204.

    https://doi.org/10.7554/eLife.62204

    • PubMed
    • Google Scholar
18. 1. Kim B
    2. Wang Y-C
    3. Hespen CW
    4. Espinosa J
    5. Salje J
    6. Rangan KJ
    7. Oren DA
    8. Kang JY
    9. Pedicord VA
    10. Hang HC

    (2019) Enterococcus faecium secreted antigen A generates muropeptides to enhance host immunity and limit bacterial pathogenesis

    eLife 8:e45343.

    https://doi.org/10.7554/eLife.45343

    • PubMed
    • Google Scholar
19. 1. Lebreton F
    2. Manson AL
    3. Saavedra JT
    4. Straub TJ
    5. Earl AM
    6. Gilmore MS

    (2017) Tracing the Enterococci from paleozoic origins to the hospital

    Cell 169:849–861.

    https://doi.org/10.1016/j.cell.2017.04.027

    • PubMed
    • Google Scholar
20. 1. Liu Y-T
    2. Zhang H
    3. Wang H
    4. Tao C-L
    5. Bi G-Q
    6. Zhou ZH

    (2022) Isotropic reconstruction for electron tomography with deep learning

    Nature Communications 13:6482.

    https://doi.org/10.1038/s41467-022-33957-8

    • PubMed
    • Google Scholar
21. 1. Mastronarde DN

    (2005) Automated electron microscope tomography using robust prediction of specimen movements

    Journal of Structural Biology 152:36–51.

    https://doi.org/10.1016/j.jsb.2005.07.007

    • PubMed
    • Google Scholar
22. 1. Mastronarde DN
    2. Held SR

    (2017) Automated tilt series alignment and tomographic reconstruction in IMOD

    Journal of Structural Biology 197:102–113.

    https://doi.org/10.1016/j.jsb.2016.07.011

    • PubMed
    • Google Scholar
23. 1. Matson V
    2. Fessler J
    3. Bao R
    4. Chongsuwat T
    5. Zha Y
    6. Alegre M-L
    7. Luke JJ
    8. Gajewski TF

    (2018) The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients

    Science 359:104–108.

    https://doi.org/10.1126/science.aao3290

    • PubMed
    • Google Scholar
24. 1. Mavrici D
    2. Marakalala MJ
    3. Holton JM
    4. Prigozhin DM
    5. Gee CL
    6. Zhang YJ
    7. Rubin EJ
    8. Alber T

    (2014) Mycobacterium tuberculosis FtsX extracellular domain activates the peptidoglycan hydrolase, RipC

    PNAS 111:8037–8042.

    https://doi.org/10.1073/pnas.1321812111

    • PubMed
    • Google Scholar
25. 1. Meisner J
    2. Montero Llopis P
    3. Sham L-T
    4. Garner E
    5. Bernhardt TG
    6. Rudner DZ

    (2013) FtsEX is required for CwlO peptidoglycan hydrolase activity during cell wall elongation in Bacillus subtilis

    Molecular Microbiology 89:1069–1083.

    https://doi.org/10.1111/mmi.12330

    • PubMed
    • Google Scholar
26. 1. Pedicord VA
    2. Lockhart AAK
    3. Rangan KJ
    4. Craig JW
    5. Loschko J
    6. Rogoz A
    7. Hang HC
    8. Mucida D

    (2016) Exploiting a host-commensal interaction to promote intestinal barrier function and enteric pathogen tolerance

    Science Immunology 1:eaai7732.

    https://doi.org/10.1126/sciimmunol.aai7732

    • PubMed
    • Google Scholar
27. 1. Rangan KJ
    2. Pedicord VA
    3. Wang Y-C
    4. Kim B
    5. Lu Y
    6. Shaham S
    7. Mucida D
    8. Hang HC

    (2016) A secreted bacterial peptidoglycan hydrolase enhances tolerance to enteric pathogens

    Science 353:1434–1437.

    https://doi.org/10.1126/science.aaf3552

    • PubMed
    • Google Scholar
28. 1. Routy B
    2. Le Chatelier E
    3. Derosa L
    4. Duong CPM
    5. Alou MT
    6. Daillère R
    7. Fluckiger A
    8. Messaoudene M
    9. Rauber C
    10. Roberti MP
    11. Fidelle M
    12. Flament C
    13. Poirier-Colame V
    14. Opolon P
    15. Klein C
    16. Iribarren K
    17. Mondragón L
    18. Jacquelot N
    19. Qu B
    20. Ferrere G
    21. Clémenson C
    22. Mezquita L
    23. Masip JR
    24. Naltet C
    25. Brosseau S
    26. Kaderbhai C
    27. Richard C
    28. Rizvi H
    29. Levenez F
    30. Galleron N
    31. Quinquis B
    32. Pons N
    33. Ryffel B
    34. Minard-Colin V
    35. Gonin P
    36. Soria J-C
    37. Deutsch E
    38. Loriot Y
    39. Ghiringhelli F
    40. Zalcman G
    41. Goldwasser F
    42. Escudier B
    43. Hellmann MD
    44. Eggermont A
    45. Raoult D
    46. Albiges L
    47. Kroemer G
    48. Zitvogel L

    (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

    Science 359:91–97.

    https://doi.org/10.1126/science.aan3706

    • PubMed
    • Google Scholar
29. 1. Seishima J
    2. Iida N
    3. Kitamura K
    4. Yutani M
    5. Wang Z
    6. Seki A
    7. Yamashita T
    8. Sakai Y
    9. Honda M
    10. Yamashita T
    11. Kagaya T
    12. Shirota Y
    13. Fujinaga Y
    14. Mizukoshi E
    15. Kaneko S

    (2019) Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host

    Genome Biology 20:252.

    https://doi.org/10.1186/s13059-019-1879-9

    • PubMed
    • Google Scholar
30. 1. Sham LT
    2. Barendt SM
    3. Kopecky KE
    4. Winkler ME

    (2011) Essential PcsB putative peptidoglycan hydrolase interacts with the essential FtsXSpn cell division protein in Streptococcus pneumoniae D39

    PNAS 108:E1061–E1069.

    https://doi.org/10.1073/pnas.1108323108

    • PubMed
    • Google Scholar
31. 1. Smith M
    2. Dai A
    3. Ghilardi G
    4. Amelsberg KV
    5. Devlin SM
    6. Pajarillo R
    7. Slingerland JB
    8. Beghi S
    9. Herrera PS
    10. Giardina P
    11. Clurman A
    12. Dwomoh E
    13. Armijo G
    14. Gomes ALC
    15. Littmann ER
    16. Schluter J
    17. Fontana E
    18. Taur Y
    19. Park JH
    20. Palomba ML
    21. Halton E
    22. Ruiz J
    23. Jain T
    24. Pennisi M
    25. Afuye AO
    26. Perales M-A
    27. Freyer CW
    28. Garfall A
    29. Gier S
    30. Nasta S
    31. Landsburg D
    32. Gerson J
    33. Svoboda J
    34. Cross J
    35. Chong EA
    36. Giralt S
    37. Gill SI
    38. Riviere I
    39. Porter DL
    40. Schuster SJ
    41. Sadelain M
    42. Frey N
    43. Brentjens RJ
    44. June CH
    45. Pamer EG
    46. Peled JU
    47. Facciabene A
    48. van den Brink MRM
    49. Ruella M

    (2022) Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

    Nature Medicine 28:713–723.

    https://doi.org/10.1038/s41591-022-01702-9

    • PubMed
    • Google Scholar
32. 1. Stein-Thoeringer CK
    2. Nichols KB
    3. Lazrak A
    4. Docampo MD
    5. Slingerland AE
    6. Slingerland JB
    7. Clurman AG
    8. Armijo G
    9. Gomes ALC
    10. Shono Y
    11. Staffas A
    12. Burgos da Silva M
    13. Devlin SM
    14. Markey KA
    15. Bajic D
    16. Pinedo R
    17. Tsakmaklis A
    18. Littmann ER
    19. Pastore A
    20. Taur Y
    21. Monette S
    22. Arcila ME
    23. Pickard AJ
    24. Maloy M
    25. Wright RJ
    26. Amoretti LA
    27. Fontana E
    28. Pham D
    29. Jamal MA
    30. Weber D
    31. Sung AD
    32. Hashimoto D
    33. Scheid C
    34. Xavier JB
    35. Messina JA
    36. Romero K
    37. Lew M
    38. Bush A
    39. Bohannon L
    40. Hayasaka K
    41. Hasegawa Y
    42. Vehreschild MJGT
    43. Cross JR
    44. Ponce DM
    45. Perales MA
    46. Giralt SA
    47. Jenq RR
    48. Teshima T
    49. Holler E
    50. Chao NJ
    51. Pamer EG
    52. Peled JU
    53. van den Brink MRM

    (2019) Lactose drives Enterococcus expansion to promote graft-versus-host disease

    Science 366:1143–1149.

    https://doi.org/10.1126/science.aax3760

    • PubMed
    • Google Scholar
33. 1. Teng F
    2. Kawalec M
    3. Weinstock GM
    4. Hryniewicz W
    5. Murray BE

    (2003) An Enterococcus faecium secreted antigen, SagA, exhibits broad-spectrum binding to extracellular matrix proteins and appears essential for E. faecium growth

    Infection and Immunity 71:5033–5041.

    https://doi.org/10.1128/IAI.71.9.5033-5041.2003

    • PubMed
    • Google Scholar
34. 1. Van Tyne D
    2. Gilmore MS

    (2014) Friend turned foe: evolution of enterococcal virulence and antibiotic resistance

    Annual Review of Microbiology 68:337–356.

    https://doi.org/10.1146/annurev-micro-091213-113003

    • PubMed
    • Google Scholar
35. 1. Wilson SA
    2. Tank RKJ
    3. Hobbs JK
    4. Foster SJ
    5. Garner EC

    (2023) An exhaustive multiple knockout approach to understanding cell wall hydrolase function in Bacillus subtilis

    mBio 14:e0176023.

    https://doi.org/10.1128/mbio.01760-23

    • PubMed
    • Google Scholar
36. 1. Yang DC
    2. Peters NT
    3. Parzych KR
    4. Uehara T
    5. Markovski M
    6. Bernhardt TG

    (2011) An ATP-binding cassette transporter-like complex governs cell-wall hydrolysis at the bacterial cytokinetic ring

    PNAS 108:E1052–E1060.

    https://doi.org/10.1073/pnas.1107780108

    • PubMed
    • Google Scholar
37. 1. Zheng SQ
    2. Palovcak E
    3. Armache J-P
    4. Verba KA
    5. Cheng Y
    6. Agard DA

    (2017) MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy

    Nature Methods 14:331–332.

    https://doi.org/10.1038/nmeth.4193

    • PubMed
    • Google Scholar

Author details

1. Steven Klupt

   Department of Immunology and Microbiology, Scripps Research, La Jolla, United States

   Contribution

   Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft, Conceived the project, Performed microbiology studies, Wrote the manuscript, which was edited by all the other authors

   Contributed equally with

   Kyong Tkhe Fam and Xing Zhang

   Competing interests

   No competing interests declared

2. Kyong Tkhe Fam

   Department of Immunology and Microbiology, Scripps Research, La Jolla, United States

   Contribution

   Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – review and editing, Performed LC-MS analysis of peptidoglycan and NOD2 activation assays, Edited the manuscript, Revised the manuscript

   Contributed equally with

   Steven Klupt and Xing Zhang

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-4877-5679

3. Xing Zhang

   Department of Immunology and Microbiology, Scripps Research, La Jolla, United States

   Contribution

   Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – review and editing, Performed immune checkpoint inhibitor antitumor and flow cytometry studies, Edited the manuscript

   Contributed equally with

   Steven Klupt and Kyong Tkhe Fam

   Competing interests

   No competing interests declared

4. Pavan Kumar Chodisetti

   Department of Immunology and Microbiology, Scripps Research, La Jolla, United States

   Contribution

   Formal analysis, Writing – review and editing, Assisted microbiology studies

   Competing interests

   No competing interests declared

5. Abeera Mehmood

   Department of Immunology and Microbiology, Scripps Research, La Jolla, United States

   Contribution

   Formal analysis, Writing – review and editing, Assisted immune checkpoint inhibitor antitumor and flow cytometry studies

   Competing interests

   No competing interests declared

6. Tumara Boyd

   Department of Integrative Structural & Computational Biology, Scripps Research, La Jolla, United States

   Contribution

   Formal analysis, Performed cryo-electron tomography analysis

   Competing interests

   No competing interests declared

7. Danielle Grotjahn

   Department of Integrative Structural & Computational Biology, Scripps Research, La Jolla, United States

   Contribution

   Resources, Writing – review and editing, Established Scripps Research cryo-ET facility, Provided training and technical assistance

   Competing interests

   No competing interests declared

8. Donghyun Park

   Department of Integrative Structural & Computational Biology, Scripps Research, La Jolla, United States

   Contribution

   Formal analysis, Performed cryo-electron tomography analysis

   Competing interests

   No competing interests declared

9. Howard C Hang

   1. Department of Immunology and Microbiology, Scripps Research, La Jolla, United States
   2. Department of Chemistry, Scripps Research, La Jolla, United States

   Contribution

   Conceptualization, Resources, Data curation, Supervision, Funding acquisition, Methodology, Writing – original draft, Project administration, Writing – review and editing, Conceived the project, Wrote the manuscript, which was edited by all the other authors, Revised the manuscript

   For correspondence

   hhang@scripps.edu

   Competing interests

   has filed patent applications (PCT/US2016/028836, PCT/US2020/019038) for the commercial use of SagA-bacteria to improve intestinal immunity and checkpoint blockade immunotherapy, which has been licensed by Rise Therapeutics for probiotic development

   "This ORCID iD identifies the author of this article:" 0000-0003-4053-5547

• 341

  views

• 36

  downloads

• 1

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.